InferRead TM CT Pneumonia
CH-RH

Fast · Accurate · Triage · Analysis

Accurate and Fast Triage:

Rapidly identify suspected pneumonia cases among others from the database for the optimal protection and safety of the patient and the community.

Precise Lesion Analysis:

Critical lesion quantifications and intelligent analysis results are provided. Lesion information such as volume and density are available in details with intelligent visualizations to help the clinicians save valuable seconds in the infectious-disease diagnosis workflow.

Advanced tool for follow-up management is provided. Clinicians can quickly assess the volume changes at different density ranges between different scans of the patient through the visualization and accurately determine the progression of the disease in follow-up studies.

Product description

Efficient reading: A study comparing imaging reading time shows that the AI-assisted diagnosis improves the overall efficiency of the radiology department.

 

High sensitivity: A multi-center clinical trial shows that InferRead CT Pneumonia has very high sensitivity [HW1] on pneumonia detection, especially on the Novel Coronavirus Pneumonia (COVID-19).

 

Lesion density analysis: The system shows density distribution via histograms. Doctors are able to quickly assess the volume changes at different density ranges from the histogram to determine the progress of the disease in follow-up studies.
 

Outcome analysis: Automatically registers and matches the studies of the same patient, provides lesion comparisons, measures changes in lesion volume, density, and staging to assist the doctors with outcome assessment.
 

Follow-up management: This product provides a follow-up management tool to enable intelligent online follow-up for high risk patients during quarantine, which allows remote tracking of patient status and help doctors arrange further exams.
 

Intelligent Report: Automatically generate structured diagnosis reports and follow-up reports for pneumonia cases based on the latest guidelines.

 

 

InferRead TM CT Pneumonia
CH-RH
With A.l., We Improve Human Life

Procedure

Efficient reading: A study comparing imaging reading time shows that the AI-assisted diagnosis improves the overall efficiency of the radiology department.

 

High sensitivity: A multi-center clinical trial shows that InferRead CT Pneumonia has very high sensitivity [HW1] on pneumonia detection, especially on the Novel Coronavirus Pneumonia (COVID-19).

 

Lesion density analysis: The system shows density distribution via histograms. Doctors are able to quickly assess the volume changes at different density ranges from the histogram to determine the progress of the disease in follow-up studies.
 

Outcome analysis: Automatically registers and matches the studies of the same patient, provides lesion comparisons, measures changes in lesion volume, density, and staging to assist the doctors with outcome assessment.
 

Follow-up management: This product provides a follow-up management tool to enable intelligent online follow-up for high risk patients during quarantine, which allows remote tracking of patient status and help doctors arrange further exams.
 

Intelligent Report: Automatically generate structured diagnosis reports and follow-up reports for pneumonia cases based on the latest guidelines.

 

 

1

InferVision North America

1900 Market Street, Fl 8th, Philadelphia, PA 19103

 

usa@infervision.com

InferVision Europe

Mainzer Straße 75, 65189 Wiesbaden, Germany

 

europe@infervision.com

InferVision China

18 / f, seat E, ocean international center, chaoyang district, Beijing

 

contact@infervision.com

InferVision APAC

30/F Shinjuku Park Tower, 3-7-1 Nishi-Shinjuku, Shinjuku-ku, Tokyo, 163-1030

 

apac@infervision.com

+81(0)3-6256-9810
 

Copyright © 2019   Beijing Infervision Technology Co., Ltd.  All Rights Reserved.   By:www.300.cn    京ICP备16032186号